Compound 2a at concentrations ≤ 20 μM was found to inhibit cellular tyrosinase activity and melanogenesis effectively and dose-dependently in α-MSH plus IBMX stimulated murine B16F10 melanoma cells. This evidence concerns the gene STAMBP and melanoma.